tranexamic acid has been researched along with tamoxifen in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Soper, DE | 1 |
| Hiramoto, K; Mafune, E; Sugiyama, D; Takahashi, Y; Yamate, Y | 1 |
| McNicholas, C; Zigler, RE | 1 |
2 review(s) available for tranexamic acid and tamoxifen
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Unscheduled vaginal bleeding with progestin-only contraceptive use.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifibrinolytic Agents; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Desogestrel; Doxycycline; Estrogens; Female; Hormone Antagonists; Humans; Intrauterine Devices, Medicated; Medroxyprogesterone Acetate; Metrorrhagia; Mifepristone; Progestins; Tamoxifen; Tranexamic Acid | 2017 |
5 other study(ies) available for tranexamic acid and tamoxifen
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
The intrauterine device: a good thing revisited.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antifibrinolytic Agents; Antineoplastic Agents, Hormonal; Biomedical Research; Breast Neoplasms; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices; Intrauterine Devices, Medicated; Levonorgestrel; Mefenamic Acid; Metrorrhagia; Pelvic Inflammatory Disease; Tamoxifen; Tranexamic Acid | 2013 |
The gender differences in the inhibitory action of UVB-induced melanocyte activation by the administration of tranexamic acid.
Topics: Adrenocorticotropic Hormone; alpha-MSH; Animals; Antifibrinolytic Agents; beta-Endorphin; Dihydroxyphenylalanine; Ear; Estradiol; Estrogen Receptor beta; Eye; Female; Male; Melanocytes; Mice; Mice, Inbred DBA; Microphthalmia-Associated Transcription Factor; Monophenol Monooxygenase; Naltrexone; Narcotic Antagonists; p38 Mitogen-Activated Protein Kinases; Receptors, Opioid, mu; Selective Estrogen Receptor Modulators; Sex Factors; Skin; Tamoxifen; Tranexamic Acid; Ultraviolet Rays | 2016 |